Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Question about Nuance deal
View:
Post by Layth1990 on Feb 10, 2021 2:35pm

Question about Nuance deal

will Nuance pay for trials that will happen in the us ? because it is a regional deal. i know cash will help us with the trials
Comment by MrMugsy on Feb 10, 2021 2:44pm
No - based on the way I read it ... they will pay for the regional trials in China - required by the Chinese equivalent of the FDA. --------- Clinical development and regulatory costs for the region will be borne by Nuance. Antibe and Nuance have established a structure for collaborating on otenaproxesul’s clinical development in the region, ensuring a fit with Antibe’s global regulatory ...more  
Comment by crow27 on Feb 10, 2021 3:10pm
Agree,  now a $6.00 Canadian dollar is worth aprox $4.75 US dollars. If the requirement is to be above a $4.00 US dollar to list on Nasdaq then we are sort of on the bubble. I believe just issuing a NR that mentiona a date that ATE is also going to be listed on the Nasdaq would spike the stock up. Once on the Nasdaq we should start to move much higher but it's the getting there that ...more  
Comment by MrMugsy on Feb 10, 2021 4:17pm
Yes ... the news release to NASDAQ will definitely create some excitement. There's lots of pre/post NASDAQ news that can come and really drive the share price up to the strategy the company is working towards. No rush, looking at all the data that still needs to come. Scratch China off this list. The potential for news is huge ... more analysts, marketing name for OTENA, updates on animal ...more  
Comment by crow27 on Feb 10, 2021 4:23pm
I'm getting dizzy with all that news that could come at anytime, hahaha.
Comment by Mole101 on Feb 10, 2021 5:50pm
I'm happy with building SP up here until We reach maybe 10$ and resolving the Antibe holdings amalgamation issue anc then go into Nasdaq ,you need a good base if sp trades sideways when it gets there .. I would love to see it perform like IPA when it moved there last year ..
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities